HRT Financial’s Mesoblast MESO Stock Holding History

HRT Financial’s Portfolio MESO Stock Details MESO Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2026 Q1	$526K	Buy	+34,223	New	+$570K	﹤0.01%	2484
2024 Q2	–	Sell	-57,815	Closed	-$289K	–	2738
2024 Q1	$289K	Buy	+57,815	New	+$123K	﹤0.01%	1573

Other funds holding MESO

BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return

Goldman Sachs New York $871B AUM 31.28% 1-Year Est. Return

Susquehanna International Group Bala Cynwyd, Pennsylvania $893B AUM 36.07% 1-Year Est. Return

UBS Group Zurich, Switzerland $666B AUM 30.12% 1-Year Est. Return

Bank of America Charlotte, North Carolina $1.37T AUM 24.88% 1-Year Est. Return

Jane Street New York $777B AUM 61.18% 1-Year Est. Return

Penbrook Management New York $132M AUM 29.91% 1-Year Est. Return

Citadel Advisors Miami, Florida $618B AUM 30.34% 1-Year Est. Return

Group One Trading Chicago, Illinois $52.2B AUM 104.56% 1-Year Est. Return

HRT Financial's MESO Position: Q1 2026 in Review

HRT Financial opened a new position in Mesoblast (MESO) in Q1 2026: 34,223 shares worth $526K. The stake represents ﹤0.01% of the portfolio and ranks #2484 among its holdings. This is a return to the name: HRT Financial previously reported a position in MESO as recently as Q1 2024.

HRT Financial first reported a position in MESO in Q1 2024 and has held it in 2 quarters since. 69 funds tracked by Wall St. Rank hold MESO as of Q1 2026.

HRT Financial held 34,223 shares of Mesoblast worth $526K as of Q1 2026.
Mesoblast was a new HRT Financial position in Q1 2026.
Mesoblast made up ﹤0.01% of HRT Financial's portfolio in Q1 2026, its #2484 holding.
HRT Financial first reported a position in Mesoblast in Q1 2024 and has held it in 2 quarters since.
69 funds tracked by Wall St. Rank held Mesoblast as of Q1 2026.

Based on HRT Financial's 13F filing for Q1 2026, filed 14 May 2026.